Cite
MLA Citation
S. Degryse et al.. “Correction: Mutant JAK3 phosphoproteomic profiling predicts synergism between JAK3 inhibitors and MEK/BCL2 inhibitors for the treatment of T-cell acute lymphoblastic leukemia.” Leukemia, vol. 32, no. 12, 2018, p. 2731. http://access.bl.uk/ark:/81055/vdc_100099710512.0x00029d